- Brain Scientific was featured in Neoscope, a publication of Futurism, a media company concentrating on the scientific and technological advances for the future
- Article details e-tattoo, BRSF’s solution that can capture big data in real-time about brain activity with possible applications in epileptic seizure predictions
- E-tattoo could prove invaluable to medical researchers studying neurological conditions or even developers building brain-computer interfaces for mind-controlled electronics, video games
Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, has been featured in Neoscope as a company that champions cutting-edge research pushing the boundaries of what is possible in the brain diagnostics field (https://ibn.fm/IOD55). Neoscope is the publication of Futurism, a New York City-based media company concentrating on the scientific and technological advances for the future.
The article details Brain Scientific’s e-tattoo technology — a series of tiny electrodes stitched beneath the skin that can get a clear reading of neural signals in real-time. Although the e-tattoo could be used to develop brain-computer interfaces for virtual reality experiences or games controlled by neural signals or for mind-controlled electronics, the immediate use of this…
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
